APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasmid DNA (pDNA)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasmid DNA (pDNA) Industry Growth and Trends Forecast to 2032

27 December 2025114 pages

Choose your research edition.

Industry ResearchPlasmid DNA (pDNA) Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasmid DNA (pDNA) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Plasmid DNA (pDNA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasmid DNA (pDNA) Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasmid DNA (pDNA) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Plasmid DNA (pDNA) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasmid DNA (pDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasmid DNA (pDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasmid DNA (pDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Plasmid DNA (pDNA) market include GenScript Biotech, Xpress Biologics, WuXi Advanced Therapies, Waisman Biomanufacturing, Takara Bio, Synbio Technologies, Recipharm, Patheon and GenScript ProBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasmid DNA (pDNA) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasmid DNA (pDNA) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasmid DNA (pDNA) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasmid DNA (pDNA).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Plasmid DNA (pDNA) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasmid DNA (pDNA) Market by Company

GenScript Biotech

Xpress Biologics

WuXi Advanced Therapies

Waisman Biomanufacturing

Takara Bio

Synbio Technologies

Recipharm

Patheon

GenScript ProBio

Eurogentec

Esco Aster

Creative Biolabs

Charles River Laboratories

Catalent Biologics

Biovian

Andelyn Biosciences

Aldevron

Akron Biotech

AGC Biologics

Plasmid DNA (pDNA) Segment by Type

Research Grade Plasmid DNA

Commercial Grade Plasmid DNA

Plasmid DNA (pDNA) Segment by Application

Cancers

Viral Infections

Inherited Disorders

Other

Plasmid DNA (pDNA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA (pDNA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA (pDNA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA (pDNA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Plasmid DNA (pDNA) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Plasmid DNA (pDNA) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Plasmid DNA (pDNA) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Plasmid DNA (pDNA) Market Share by Region (2021-2026) Table 4. Global Plasmid DNA (pDNA) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Plasmid DNA (pDNA) Market Share by Region (2027-2032) Table 6. Global Plasmid DNA (pDNA) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Plasmid DNA (pDNA) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Plasmid DNA (pDNA) Market Size Share by Type (2021-2026) Table 9. Global Plasmid DNA (pDNA) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Plasmid DNA (pDNA) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Plasmid DNA (pDNA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Plasmid DNA (pDNA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Plasmid DNA (pDNA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Plasmid DNA (pDNA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Plasmid DNA (pDNA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Plasmid DNA (pDNA) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Plasmid DNA (pDNA) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Plasmid DNA (pDNA) Market Size Share by Application (2021-2026) Table 24. Global Plasmid DNA (pDNA) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Plasmid DNA (pDNA) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Plasmid DNA (pDNA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Plasmid DNA (pDNA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Plasmid DNA (pDNA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Plasmid DNA (pDNA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Plasmid DNA (pDNA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Plasmid DNA (pDNA) Industry Trends Table 37. Plasmid DNA (pDNA) Industry Drivers Table 38. Plasmid DNA (pDNA) Industry Opportunities and Challenges Table 39. Plasmid DNA (pDNA) Industry Restraints Table 40. Global Plasmid DNA (pDNA) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Plasmid DNA (pDNA) Revenue Market Share by Company (2021-2026) Table 42. Global Plasmid DNA (pDNA) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Plasmid DNA (pDNA) Key Company Headquarters & Area Served Table 44. Global Plasmid DNA (pDNA) Company, Product Type & Application Table 45. Global Plasmid DNA (pDNA) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Plasmid DNA (pDNA) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GenScript Biotech Company Information Table 49. GenScript Biotech Business Overview Table 50. GenScript Biotech Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GenScript Biotech Plasmid DNA (pDNA) Product Portfolio Table 52. GenScript Biotech Recent Development Table 53. Xpress Biologics Company Information Table 54. Xpress Biologics Business Overview Table 55. Xpress Biologics Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Xpress Biologics Plasmid DNA (pDNA) Product Portfolio Table 57. Xpress Biologics Recent Development Table 58. WuXi Advanced Therapies Company Information Table 59. WuXi Advanced Therapies Business Overview Table 60. WuXi Advanced Therapies Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio Table 62. WuXi Advanced Therapies Recent Development Table 63. Waisman Biomanufacturing Company Information Table 64. Waisman Biomanufacturing Business Overview Table 65. Waisman Biomanufacturing Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio Table 67. Waisman Biomanufacturing Recent Development Table 68. Takara Bio Company Information Table 69. Takara Bio Business Overview Table 70. Takara Bio Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Takara Bio Plasmid DNA (pDNA) Product Portfolio Table 72. Takara Bio Recent Development Table 73. Synbio Technologies Company Information Table 74. Synbio Technologies Business Overview Table 75. Synbio Technologies Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Synbio Technologies Plasmid DNA (pDNA) Product Portfolio Table 77. Synbio Technologies Recent Development Table 78. Recipharm Company Information Table 79. Recipharm Business Overview Table 80. Recipharm Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Recipharm Plasmid DNA (pDNA) Product Portfolio Table 82. Recipharm Recent Development Table 83. Patheon Company Information Table 84. Patheon Business Overview Table 85. Patheon Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Patheon Plasmid DNA (pDNA) Product Portfolio Table 87. Patheon Recent Development Table 88. GenScript ProBio Company Information Table 89. GenScript ProBio Business Overview Table 90. GenScript ProBio Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. GenScript ProBio Plasmid DNA (pDNA) Product Portfolio Table 92. GenScript ProBio Recent Development Table 93. Eurogentec Company Information Table 94. Eurogentec Business Overview Table 95. Eurogentec Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eurogentec Plasmid DNA (pDNA) Product Portfolio Table 97. Eurogentec Recent Development Table 98. Esco Aster Company Information Table 99. Esco Aster Business Overview Table 100. Esco Aster Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Esco Aster Plasmid DNA (pDNA) Product Portfolio Table 102. Esco Aster Recent Development Table 103. Creative Biolabs Company Information Table 104. Creative Biolabs Business Overview Table 105. Creative Biolabs Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Creative Biolabs Plasmid DNA (pDNA) Product Portfolio Table 107. Creative Biolabs Recent Development Table 108. Charles River Laboratories Company Information Table 109. Charles River Laboratories Business Overview Table 110. Charles River Laboratories Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio Table 112. Charles River Laboratories Recent Development Table 113. Catalent Biologics Company Information Table 114. Catalent Biologics Business Overview Table 115. Catalent Biologics Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Catalent Biologics Plasmid DNA (pDNA) Product Portfolio Table 117. Catalent Biologics Recent Development Table 118. Biovian Company Information Table 119. Biovian Business Overview Table 120. Biovian Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Biovian Plasmid DNA (pDNA) Product Portfolio Table 122. Biovian Recent Development Table 123. Andelyn Biosciences Company Information Table 124. Andelyn Biosciences Business Overview Table 125. Andelyn Biosciences Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio Table 127. Andelyn Biosciences Recent Development Table 128. Aldevron Company Information Table 129. Aldevron Business Overview Table 130. Aldevron Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Aldevron Plasmid DNA (pDNA) Product Portfolio Table 132. Aldevron Recent Development Table 133. Akron Biotech Company Information Table 134. Akron Biotech Business Overview Table 135. Akron Biotech Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Akron Biotech Plasmid DNA (pDNA) Product Portfolio Table 137. Akron Biotech Recent Development Table 138. AGC Biologics Company Information Table 139. AGC Biologics Business Overview Table 140. AGC Biologics Plasmid DNA (pDNA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. AGC Biologics Plasmid DNA (pDNA) Product Portfolio Table 142. AGC Biologics Recent Development Table 143. North America Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Plasmid DNA (pDNA) Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Plasmid DNA (pDNA) Market Share by Country (2021-2026) Table 146. North America Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Plasmid DNA (pDNA) Market Share Forecast by Country (2027-2032) Table 148. Europe Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Plasmid DNA (pDNA) Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Plasmid DNA (pDNA) Market Share by Country (2021-2026) Table 151. Europe Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Plasmid DNA (pDNA) Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Plasmid DNA (pDNA) Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Plasmid DNA (pDNA) Market Share by Country (2021-2026) Table 156. Asia-Pacific Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Plasmid DNA (pDNA) Market Share Forecast by Country (2027-2032) Table 158. Latin America Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Plasmid DNA (pDNA) Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Plasmid DNA (pDNA) Market Share by Country (2021-2026) Table 161. Latin America Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Plasmid DNA (pDNA) Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Plasmid DNA (pDNA) Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Plasmid DNA (pDNA) Market Share by Country (2021-2026) Table 166. Middle East & Africa Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Plasmid DNA (pDNA) Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Plasmid DNA (pDNA) Product Image Figure 3. Global Plasmid DNA (pDNA) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Plasmid DNA (pDNA) Market Size (2021-2032) & (US$ Million) Figure 5. Global Plasmid DNA (pDNA) Market Share by Region: 2025 VS 2032 Figure 6. Global Plasmid DNA (pDNA) Market Share by Region (2021-2032) Figure 7. North America Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Research Grade Plasmid DNA Image Figure 13. Global Research Grade Plasmid DNA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Commercial Grade Plasmid DNA Image Figure 15. Global Commercial Grade Plasmid DNA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Plasmid DNA (pDNA) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Plasmid DNA (pDNA) Market Share by Type 2025 VS 2032 Figure 18. North America Plasmid DNA (pDNA) Market Size Share by Type (2021-2032) Figure 19. Europe Plasmid DNA (pDNA) Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Plasmid DNA (pDNA) Market Size Share by Type (2021-2032) Figure 21. Latin America Plasmid DNA (pDNA) Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Plasmid DNA (pDNA) Market Size Share by Type (2021-2032) Figure 23. Cancers Image Figure 24. Global Cancers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Viral Infections Image Figure 26. Global Viral Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Inherited Disorders Image Figure 28. Global Inherited Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Plasmid DNA (pDNA) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Plasmid DNA (pDNA) Market Share by Application 2025 VS 2032 Figure 33. North America Plasmid DNA (pDNA) Market Size Share by Application (2021-2032) Figure 34. Europe Plasmid DNA (pDNA) Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Plasmid DNA (pDNA) Market Size Share by Application (2021-2032) Figure 36. Latin America Plasmid DNA (pDNA) Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Plasmid DNA (pDNA) Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Plasmid DNA (pDNA) Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Plasmid DNA (pDNA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Plasmid DNA (pDNA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Plasmid DNA (pDNA) Market Share by Country (2021-2032) Figure 43. Europe Plasmid DNA (pDNA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Plasmid DNA (pDNA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Plasmid DNA (pDNA) Market Share by Country (2021-2032) Figure 46. Asia-Pacific Plasmid DNA (pDNA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Plasmid DNA (pDNA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Plasmid DNA (pDNA) Market Share by Country (2021-2032) Figure 49. Latin America Plasmid DNA (pDNA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Plasmid DNA (pDNA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Plasmid DNA (pDNA) Market Share by Country (2021-2032) Figure 52. Middle East & Africa Plasmid DNA (pDNA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Plasmid DNA (pDNA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Plasmid DNA (pDNA) Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade Plasmid DNA
  • Commercial Grade Plasmid DNA
Applications
  • Cancers
  • Viral Infections
  • Inherited Disorders
  • Other
Companies covered
  • GenScript Biotech
  • Xpress Biologics
  • WuXi Advanced Therapies
  • Waisman Biomanufacturing
  • Takara Bio
  • Synbio Technologies
  • Recipharm
  • Patheon
  • GenScript ProBio
  • Eurogentec
  • Esco Aster
  • Creative Biolabs
  • Charles River Laboratories
  • Catalent Biologics
  • Biovian
  • Andelyn Biosciences
  • Aldevron
  • Akron Biotech
  • AGC Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Plasmid DNA (pDNA) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Plasmid DNA (pDNA) Market Size by Region (2021-2032)
  5. 1.4.1 Global Plasmid DNA (pDNA) Market Size by Region (2021-2026)
  6. 1.4.2 Global Plasmid DNA (pDNA) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Plasmid DNA (pDNA) Market Size (2021-2032)
  8. 1.5.1 North America Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Plasmid DNA (pDNA) Market Size Growth Rate (2021-2032)
2 Plasmid DNA (pDNA) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Research Grade Plasmid DNA
  3. 2.1.2 Commercial Grade Plasmid DNA
  4. 2.2 Global Plasmid DNA (pDNA) Market Size by Type
  5. 2.2.1 Global Plasmid DNA (pDNA) Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Plasmid DNA (pDNA) Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Plasmid DNA (pDNA) Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Plasmid DNA (pDNA) Market Size by Regions
  9. 2.3.1 North America Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Plasmid DNA (pDNA) Market Size Breakdown by Type (2021-2026)
3 Plasmid DNA (pDNA) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancers
  3. 3.1.2 Viral Infections
  4. 3.1.3 Inherited Disorders
  5. 3.1.4 Other
  6. 3.2 Global Plasmid DNA (pDNA) Market Size by Application
  7. 3.2.1 Global Plasmid DNA (pDNA) Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Plasmid DNA (pDNA) Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Plasmid DNA (pDNA) Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Plasmid DNA (pDNA) Market Size by Regions
  11. 3.3.1 North America Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Plasmid DNA (pDNA) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Plasmid DNA (pDNA) Industry Trends
  2. 4.2 Plasmid DNA (pDNA) Industry Drivers
  3. 4.3 Plasmid DNA (pDNA) Industry Opportunities and Challenges
  4. 4.4 Plasmid DNA (pDNA) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Plasmid DNA (pDNA) Revenue (2021-2026)
  2. 5.2 Global Plasmid DNA (pDNA) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Plasmid DNA (pDNA) Key Company Headquarters & Area Served
  4. 5.4 Global Plasmid DNA (pDNA) Company, Product Type & Application
  5. 5.5 Global Plasmid DNA (pDNA) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Plasmid DNA (pDNA) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Plasmid DNA (pDNA) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Plasmid DNA (pDNA) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GenScript Biotech
  2. 6.1.1 GenScript Biotech Company Information
  3. 6.1.2 GenScript Biotech Business Overview
  4. 6.1.3 GenScript Biotech Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GenScript Biotech Plasmid DNA (pDNA) Product Portfolio
  6. 6.1.5 GenScript Biotech Recent Developments
  7. 6.2 Xpress Biologics
  8. 6.2.1 Xpress Biologics Company Information
  9. 6.2.2 Xpress Biologics Business Overview
  10. 6.2.3 Xpress Biologics Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Xpress Biologics Plasmid DNA (pDNA) Product Portfolio
  12. 6.2.5 Xpress Biologics Recent Developments
  13. 6.3 WuXi Advanced Therapies
  14. 6.3.1 WuXi Advanced Therapies Company Information
  15. 6.3.2 WuXi Advanced Therapies Business Overview
  16. 6.3.3 WuXi Advanced Therapies Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio
  18. 6.3.5 WuXi Advanced Therapies Recent Developments
  19. 6.4 Waisman Biomanufacturing
  20. 6.4.1 Waisman Biomanufacturing Company Information
  21. 6.4.2 Waisman Biomanufacturing Business Overview
  22. 6.4.3 Waisman Biomanufacturing Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio
  24. 6.4.5 Waisman Biomanufacturing Recent Developments
  25. 6.5 Takara Bio
  26. 6.5.1 Takara Bio Company Information
  27. 6.5.2 Takara Bio Business Overview
  28. 6.5.3 Takara Bio Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Takara Bio Plasmid DNA (pDNA) Product Portfolio
  30. 6.5.5 Takara Bio Recent Developments
  31. 6.6 Synbio Technologies
  32. 6.6.1 Synbio Technologies Company Information
  33. 6.6.2 Synbio Technologies Business Overview
  34. 6.6.3 Synbio Technologies Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Synbio Technologies Plasmid DNA (pDNA) Product Portfolio
  36. 6.6.5 Synbio Technologies Recent Developments
  37. 6.7 Recipharm
  38. 6.7.1 Recipharm Company Information
  39. 6.7.2 Recipharm Business Overview
  40. 6.7.3 Recipharm Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Recipharm Plasmid DNA (pDNA) Product Portfolio
  42. 6.7.5 Recipharm Recent Developments
  43. 6.8 Patheon
  44. 6.8.1 Patheon Company Information
  45. 6.8.2 Patheon Business Overview
  46. 6.8.3 Patheon Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Patheon Plasmid DNA (pDNA) Product Portfolio
  48. 6.8.5 Patheon Recent Developments
  49. 6.9 GenScript ProBio
  50. 6.9.1 GenScript ProBio Company Information
  51. 6.9.2 GenScript ProBio Business Overview
  52. 6.9.3 GenScript ProBio Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 GenScript ProBio Plasmid DNA (pDNA) Product Portfolio
  54. 6.9.5 GenScript ProBio Recent Developments
  55. 6.10 Eurogentec
  56. 6.10.1 Eurogentec Company Information
  57. 6.10.2 Eurogentec Business Overview
  58. 6.10.3 Eurogentec Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eurogentec Plasmid DNA (pDNA) Product Portfolio
  60. 6.10.5 Eurogentec Recent Developments
  61. 6.11 Esco Aster
  62. 6.11.1 Esco Aster Company Information
  63. 6.11.2 Esco Aster Business Overview
  64. 6.11.3 Esco Aster Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Esco Aster Plasmid DNA (pDNA) Product Portfolio
  66. 6.11.5 Esco Aster Recent Developments
  67. 6.12 Creative Biolabs
  68. 6.12.1 Creative Biolabs Company Information
  69. 6.12.2 Creative Biolabs Business Overview
  70. 6.12.3 Creative Biolabs Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Creative Biolabs Plasmid DNA (pDNA) Product Portfolio
  72. 6.12.5 Creative Biolabs Recent Developments
  73. 6.13 Charles River Laboratories
  74. 6.13.1 Charles River Laboratories Company Information
  75. 6.13.2 Charles River Laboratories Business Overview
  76. 6.13.3 Charles River Laboratories Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio
  78. 6.13.5 Charles River Laboratories Recent Developments
  79. 6.14 Catalent Biologics
  80. 6.14.1 Catalent Biologics Company Information
  81. 6.14.2 Catalent Biologics Business Overview
  82. 6.14.3 Catalent Biologics Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Catalent Biologics Plasmid DNA (pDNA) Product Portfolio
  84. 6.14.5 Catalent Biologics Recent Developments
  85. 6.15 Biovian
  86. 6.15.1 Biovian Company Information
  87. 6.15.2 Biovian Business Overview
  88. 6.15.3 Biovian Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Biovian Plasmid DNA (pDNA) Product Portfolio
  90. 6.15.5 Biovian Recent Developments
  91. 6.16 Andelyn Biosciences
  92. 6.16.1 Andelyn Biosciences Company Information
  93. 6.16.2 Andelyn Biosciences Business Overview
  94. 6.16.3 Andelyn Biosciences Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio
  96. 6.16.5 Andelyn Biosciences Recent Developments
  97. 6.17 Aldevron
  98. 6.17.1 Aldevron Company Information
  99. 6.17.2 Aldevron Business Overview
  100. 6.17.3 Aldevron Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Aldevron Plasmid DNA (pDNA) Product Portfolio
  102. 6.17.5 Aldevron Recent Developments
  103. 6.18 Akron Biotech
  104. 6.18.1 Akron Biotech Company Information
  105. 6.18.2 Akron Biotech Business Overview
  106. 6.18.3 Akron Biotech Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Akron Biotech Plasmid DNA (pDNA) Product Portfolio
  108. 6.18.5 Akron Biotech Recent Developments
  109. 6.19 AGC Biologics
  110. 6.19.1 AGC Biologics Company Information
  111. 6.19.2 AGC Biologics Business Overview
  112. 6.19.3 AGC Biologics Plasmid DNA (pDNA) Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 AGC Biologics Plasmid DNA (pDNA) Product Portfolio
  114. 6.19.5 AGC Biologics Recent Developments
7 North America
  1. 7.1 North America Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Plasmid DNA (pDNA) Market Size by Country (2021-2026)
  3. 7.3 North America Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Plasmid DNA (pDNA) Market Size by Country (2021-2026)
  3. 8.3 Europe Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Plasmid DNA (pDNA) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Plasmid DNA (pDNA) Market Size by Country (2021-2026)
  3. 10.3 South America Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Plasmid DNA (pDNA) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Plasmid DNA (pDNA) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst